Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Zimmer Biomet Holdings (ZBH)
NYSE:ZBH
Holding ZBH?
Track your performance easily
ZBH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$101.38 - $142.06
Previous Close$108.69
Volume1.82M
Average Volume (3M)1.50M
Market Cap
$22.36B
Enterprise Value$27.72B
Total Cash (Recent Filing)$415.80M
Total Debt (Recent Filing)$5.77B
Price to Earnings (P/E)23.5
Beta0.93
Next Earnings
Aug 07, 2024EPS Estimate
$1.99Last Dividend Ex-Date
Jun 26, 2024Dividend Yield0.88%
Share Statistics
EPS (TTM)4.62
Shares Outstanding205,728,398
10 Day Avg. Volume1,975,463
30 Day Avg. Volume1,502,808
Standard Deviation0.08
R-Squared0.45
Alpha-0.00845
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)1.78
Price to Sales (P/S)3.00
Price to Cash Flow (P/CF)9.40
P/FCF Ratio9.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.75
Enterprise Value/Gross Profit5.22
Enterprise Value/Ebitda24.47
Forecast
1Y Price Target
$132.37Price Target Upside24.26% Upside
Rating ConsensusHold
Number of Analyst Covering21
Zimmer Biomet Holdings News
Bulls Say, Bears Say
Bulls Say
Financial GrowthZimmer Biomet expects revenue to grow at a rate higher than the market average, with earnings per share projected to grow at least 1.5 times the revenue growth.
Product InnovationZimmer Biomet plans to launch nearly 30 new products this year, with over 50 more in the long-range plan, highlighting its commitment to innovation.
Strategic PartnershipsA new exclusive agreement with THINK Surgical allows Zimmer Biomet to integrate its technologies into the TMINI robotic platform, enhancing its competitiveness in the ASC market.
Bears Say
Company PerformanceZimmer Biomet's global recon market share was down ~80 bps Y/Y with its global knee share down ~60 bps Y/Y and its global hip share down ~120 bps Y/Y.
EarningsLimited upside to consensus EPS estimates, with projected earnings growth more dependent on financial leverage vs. operating leverage.
GrowthManagement's unchanged guidance/2Q commentary suggests revenue growth is likely to slow over the next few quarters.
---
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
ZBH FAQ
What was Zimmer Biomet Holdings’s price range in the past 12 months?
Zimmer Biomet Holdings lowest stock price was $101.38 and its highest was $142.06 in the past 12 months.
What is Zimmer Biomet Holdings’s market cap?
Currently, no data Available
When is Zimmer Biomet Holdings’s upcoming earnings report date?
Zimmer Biomet Holdings’s upcoming earnings report date is Aug 07, 2024 which is 138 days ago.
How were Zimmer Biomet Holdings’s earnings last quarter?
Zimmer Biomet Holdings released its earnings results on May 02, 2024. The company reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.87 by $0.07.
Is Zimmer Biomet Holdings overvalued?
According to Wall Street analysts Zimmer Biomet Holdings’s price is currently Undervalued.
Does Zimmer Biomet Holdings pay dividends?
Zimmer Biomet Holdings pays a Quarterly dividend of $0.239 which represents an annual dividend yield of 0.88%. See more information on Zimmer Biomet Holdings dividends here
What is Zimmer Biomet Holdings’s EPS estimate?
Zimmer Biomet Holdings’s EPS estimate is $1.99.
How many shares outstanding does Zimmer Biomet Holdings have?
Zimmer Biomet Holdings has 205,728,400 shares outstanding.
What happened to Zimmer Biomet Holdings’s price movement after its last earnings report?
Zimmer Biomet Holdings reported an EPS of $1.94 in its last earnings report, beating expectations of $1.87. Following the earnings report the stock price went down -0.914%.
Which hedge fund is a major shareholder of Zimmer Biomet Holdings?
Among the largest hedge funds holding Zimmer Biomet Holdings’s share is Dodge & Cox. It holds Zimmer Biomet Holdings’s shares valued at 2B.
---
Zimmer Biomet Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$132.37 (24.26% Upside)
$132.37 (24.26% Upside)
Blogger Sentiment
Bullish
ZBH Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 5.2M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 0.3%
Last 30 Days ▲ 4.7%
Last 30 Days ▲ 4.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-23.17%
12-Months-Change
Fundamentals
Return on Equity
7.79%
Trailing 12-Months
Asset Growth
0.98%
Trailing 12-Months
Company Description
Zimmer Biomet Holdings
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company engages in designing, manufacturing and marketing orthopedic reconstructive products; biologics, sports medicine, extremities and trauma products; spine, dental implants, bone healing, craniomaxillofacial and thoracic products; and related surgical products.
---
ZBH Earnings Call
Q1 2024
0:00 / 0:00
---
ZBH Net sales Breakdown
41.09% Knees
26.60% Hips
23.70% S.E.T
8.60% Other
---
ZBH Stock 12 Month Forecast
Average Price Target
$132.37
▲(24.26% Upside)
Technical Analysis
Best Analysts Covering ZBH
1 Year
1 Year Success Rate
29/43 ratings generated profit
1 Year Average Return
+5.87%
reiterated a buy rating 7 months ago
Copying Steven Lichtman's trades and holding each position for 1 Year would result in 67.44% of your transactions generating a profit, with an average return of +5.87% per trade.
---